Latest Market News

Spheria Emerging Companies reported a sharp fall in FY2026 profit after tax after its portfolio returned just 0.3%, well behind the 8.1% benchmark. Monthly fully franked dividends continue and the listed investment company avoided a conversion vote after trading at a premium to NTA.

Overwatch Technologies is seeking A$8 million to fund an ASX listing and expand its drone-enabled maritime intelligence business. The company has A$3.8 million of contracted orders, but has yet to recognise revenue and reported an inaugural loss of A$857,604.

QEM has completed its move into Idaho, acquiring the Big It and Garden Valley projects and outlining staged exploration of historical tungsten, antimony, gold and rare-metal targets. The company ended September with $3.98 million in cash while keeping major Julia Creek expenditure on hold.

Orora says strong Cans growth is no longer enough to offset weaker Saverglass earnings, with Group EBIT expected to decline in FY27. The company is targeting more than €30 million in Glass EBIT improvement by FY30 after a €449.7 million non-cash impairment.

Qualitas delivered record deployment and stronger earnings in FY26, while raising its dividend and entering Europe through the Starz Real Estate acquisition. The alternative investment manager is guiding to normalised NPBT of $74 million to $80 million for FY27, subject to market conditions.

Biotron has appointed Glenn Gilbert as chief executive and executive director, bringing more than two decades of pharmaceutical, medical device and diagnostics experience to the company’s SedRx and antiviral programs. His package combines a $250,000 salary with up to 100 million performance-based options and $230,000 in milestone-linked cash bonuses.

Podium Minerals has improved flotation recovery at its Parks Reef PGM project to 67% while maintaining overall concentrator recovery near 80%, with a smaller targeted downstream circuit. The September quarter also delivered the full A$4 million underwritten raising and a proposed Australia-US processing partnership, though both the flowsheet and funding pathway still require further validation.

Grange Resources has approved a lower-capital underground development at Savage River, targeting a 43% project IRR and production continuity to at least 2035. The Sub-Level Cave plan is designed to be funded from existing cash and operating cashflow while preserving the option of a larger Block Cave mine.

Latrobe Magnesium has given eligible shareholders an additional 10 days to participate in its fully underwritten entitlement offer, citing market volatility and delays in receiving offer documents. The revised deadline is 26 October, with new shares expected to begin trading on 3 November.

Euroz Hartleys says several conditions for its A$145 million sale of the Capital Markets business to BMO have now been satisfied, leaving shareholder approval and Canadian Bank Act approval among the key remaining gates. Completion remains on track for the December quarter.

Pengana Private Equity Trust will target cash distributions of at least 6% a year as portfolio realisations accelerate, led by progressive sales of SpaceX. The trust will also abandon its formulaic buyback allocation framework in favour of a more opportunistic approach.

ReNerve has received supportive FDA feedback on the preclinical and testing pathway for its NervAlign Nerve Guide Matrix. The guidance sharpens the route towards a US submission, but does not amount to clearance and leaves the submission timetable open.